Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JUPITER LIFE LINE HOSPITALS LTD.

NSE : JLHLBSE : 543980ISIN CODE : INE682M01012Industry : Hospital & Healthcare ServicesHouse : Private

BSE1525.10-4.75 (-0.31 %)

PREV CLOSE ( ) 1529.85

OPEN PRICE ( ) 1541.00

BID PRICE (QTY) 1521.30 (7)

OFFER PRICE (QTY) 1525.40 (7)

VOLUME 535

TODAY'S LOW / HIGH ( )1516.40 1547.95

52 WK LOW / HIGH ( )1250 1759

NSE1522.10-8.5 (-0.56 %)

PREV CLOSE( ) 1530.60

OPEN PRICE ( ) 1533.00

BID PRICE (QTY) 1522.30 (1)

OFFER PRICE (QTY) 1523.50 (1)

VOLUME 11085

TODAY'S LOW / HIGH( ) 1514.80 1547.80

52 WK LOW / HIGH ( )1248.95 1770

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 2002

Management Info

Ajay Thakker - Chairman Ajay Thakker - Managing Director

Registered Office

Address 1004, 10th Floor, 360 Degree Business Park,Maharana Pratap Chowk, L B S Marg,Mulund (West),
Mumbai,
Maharashtra-400080

Phone 022-21725623

Email info@jupiterhospital.com

Website www.jupiterhospital.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

17Jun Jupiter Life Line Hospitals informs ab
Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obli..

17Jun Jupiter Life Line Hospitals submits BRSR
Pursuant to the provision of Regulation 34(2)(f) of the SEBI (Listing Ob..

09May Appointment of Director
Inter alia, approved:- 1. Recommendation of a dividend @ 10 % i.e. Rs.1..

09May Appointment of CEO
Inter alia, approved:- 1. Recommendation of a dividend @ 10 % i.e. Rs.1..

09May Amalgamation
Inter alia, approved:- 1. Recommendation of a dividend @ 10 % i.e. Rs.1..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	444.47	1847.02
Gross Profit	617.81	2463.44
Operating Profit	791.6	2973.57
Net Sales	2739.13	10599.98

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 4478.00 (0.69%)	M.Cap ( in Cr)2104.66
Yatharth Hospital (BSE) 628.50 (3.90%)	M.Cap ( in Cr)6041.42
Krsnaa Diagnostics (BSE) 758.80 (2.54%)	M.Cap ( in Cr)2461.45
Dr. Lal Pathlabs (BSE) 2872.00 (0.65%)	M.Cap ( in Cr)24060.33
Global Health (BSE) 1214.90 (1.07%)	M.Cap ( in Cr)32626.04

Shareholding Pattern

	PROMOTERS	40.91%
	NON-INSTITUTION	36.84%
	MUTUAL FUNDS/UTI	11.09%
	FI/BANKS/INSURANCE	0.94%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
SBI Healthcare Opp ...	3.54
UTI Healthcare Fund...	3.07
Aditya Birla SL Pha...	2.57
PGIM India Healthca...	2.55
HDFC Non-Cyclical C...	2.05
SBI Midcap Fund-Reg(G)	1.75
Tata Children's Fun...	1.58

Risk Disclosures on Derivatives

Smart Quotes

JUPITER LIFE LINE HOSPITALS LTD.